...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Promissory Note

Hi OT what are terms of the note.Are you sure the warrants are not a conversion option otherwise free ride for 4 years doesn't make financial sense.It also doesn't add up when the Exempt issue wts expire  in 1 year

Share
New Message
Please login to post a reply